Evidence map›Paper›PMID 23110135›Full record

ArticlePloS one2012

Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences.

Patrick A Randall, Marta Pardo, Eric J Nunes, Laura López Cruz, V Kiran Vemuri, Alex Makriyannis, Younis Baqi, Christa E Müller, Mercè Correa, John D Salamone

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 1 synthesis or guideline pooled it, 194 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. A2A-Positive Neurons in the Nucleus Accumbens Core Regulate Effort Exertion.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  12. Inhibition of striatal indirect pathway during second postnatal week leads to long-lasting deficits in motivated behavior.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  18. Article
  19. Article
  20. Neuropsychological Effects of Antidepressants: Translational Studies.Current topics in behavioral neurosciences · 2024
    Review

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Patrick A RandallDepartment of Psychology, University of Connecticut, Storrs, United States of America.
Marta Pardo
Eric J Nunes
Laura López Cruz
V Kiran Vemuri
Alex Makriyannis
Younis Baqi
Christa E Müller
Mercè Correa
John D Salamone
Universitat Jaume I · ESUniversity of Connecticut · USNortheastern University · USUniversity of Bonn · DE

Funding

Cannabinergic Medications for Methamphetamine AddictionR37DA023142 · NIDA · NORTHEASTERN UNIVERSITY · PI MAKRIYANNIS, ALEXANDROS · 2007 to 2016
$7.1M
CT Research Center for Criminal Justice Drug Abuse Treatment Study CenterU01DA016194 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI FRISMAN, LINDA K · 2002 to 2012
$6.4M
Effort-related Functions of Nucleus Accumbens Adenosine A2A ReceptorsR01MH078023 · NIMH · UNIVERSITY OF CONNECTICUT STORRS · PI SALAMONE, JOHN D · 2007 to 2010
$835k
NIDA NIH HHS R37 DA023142NIDA NIH HHS U01 DA016194NIDA NIH HHS U01DA016194NIMH NIH HHS MH078023NIMH NIH HHS R01 MH078023
6 · The paper itself

Abstract

Mesolimbic dopamine (DA) is involved in behavioral activation and effort-related processes. Rats with impaired DA transmission reallocate their instrumental behavior away from food-reinforced tasks with high response requirements, and instead select less effortful food-seeking behaviors. In the present study, the effects of several drug treatments were assessed using a progressive ratio (PROG)/chow feeding concurrent choice task. With this task, rats can lever press on a PROG schedule reinforced by a preferred high-carbohydrate food pellet, or alternatively approach and consume the less-preferred but concurrently available laboratory chow. Rats pass through each ratio level 15 times, after which the ratio requirement is incremented by one additional response. The DA D(2) antagonist haloperidol (0.025-0.1 mg/kg) reduced number of lever presses and highest ratio achieved but did not reduce chow intake. In contrast, the adenosine A(2A) antagonist MSX-3 increased lever presses and highest ratio achieved, but decreased chow consumption. The cannabinoid CB1 inverse agonist and putative appetite suppressant AM251 decreased lever presses, highest ratio achieved, and chow intake; this effect was similar to that produced by pre-feeding. Furthermore, DA-related signal transduction activity (pDARPP-32(Thr34) expression) was greater in nucleus accumbens core of high responders (rats with high lever pressing output) compared to low responders. Thus, the effects of DA antagonism differed greatly from those produced by pre-feeding or reduced CB1 transmission, and it appears unlikely that haloperidol reduces PROG responding because of a general reduction in primary food motivation or the unconditioned reinforcing properties of food. Furthermore, accumbens core signal transduction activity is related to individual differences in work output.

Indexed as

Individuality3,3'-DiaminobenzidineAdenosine A2 Receptor AntagonistsAnalysis of VarianceAnimal FeedAnimal Nutritional Physiological PhenomenaAnimalsChoice BehaviorDopamineDopamine and cAMP-Regulated Phosphoprotein 32Dopamine AntagonistsFeeding BehaviorHaloperidolImmunohistochemistryMalePiperidines3,3'-DiaminobenzidineAdenosine A2 Receptor AntagonistsAM 251DopamineDopamine and cAMP-Regulated Phosphoprotein 32Dopamine AntagonistsHaloperidolMSX 3 compoundPiperidinesPpp1r1b protein, ratPyrazolesXanthines

Identifiers

PMID23110135
PMCPMC3478264
OpenAlexW1966867115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.